In the 1970s, broad surveys again showed that catatonia was as common as before among patients with mania and depression, and as a toxic response to neuroleptic drugs. The latter recognition, that the neuroleptic malignant syndrome is the same syndrome as malignant catatonia, and is effectively treated as such, sparked a renewed interest. Clinicians developed rating scales to identify the catatonia syndrome and applied the immediate relief afforded by a barbiturate or a benzodiazepine as a diagnostic test, the lorazepam test. Effective treatments were described as high doses of benzodiazepines and electroconvulsive therapy (ECT).
Surveys using catatonia rating scales showed catatonia to have many faces. Catatonia is presently limited to a type of schizophrenia in the psychiatric classification. Its recognition as a disorder of its own, such as delirium and dementia, should now be recognized. This experience reinforced the utility of the medical model for diagnosis. An application for melancholia is described.
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The progress of science . . . [is] . . . not wholly unlike a pack of hounds, which, in the long-run, perhaps catches its game, but where, nevertheless, when at fault, each individual goes his own way, by scent, not by sight, some running back and some forward; where the louder-voiced bring many to follow them, nearly as often in a wrong path as in a right one; where the entire pack even has been known to move off bodily on a false scent. 1 -SP Langley, 1888 C atatonia is the syndrome of disturbed motor functions amid disturbances in mood and thought. It is often acute in onset and life-threatening in severity. Credit for carving it out of clinical populations is ascribed to the German psychiatrist Karl Kahlbaum. 2 He characterized a syndrome of mutism, negativism, posturing, grimacing, staring, mannerisms, and echophenomena among psychotic and mood disturbed patients as catatonia, an illness with a fluctuating course and often with good outcome, not tied to any specific disease.
The description was persuasive and others quickly recognized the syndrome among asylum patients. However, similar to a maiden aunt, catatonia has been occasionally seen in the clinical background, remarked on for its odd appearances, and only occasionally acknowledged. A few decades ago, the syndrome seemed to have disappeared, leading to conjectures that its disappearance resulted from the introduction of new antipsychotic drugs.
Nonetheless, the reverse might have been true, for our interest in catatonia was revived by the recognition of an acute neurotoxic syndrome that mimicked Kahlbaum's classical syndrome. It took almost 2 decades of professional argument for NMS to be recognized as a variant of MC that could best be treated as such. The almost haphazard circumstances under which psychiatric syndromes appear and disappear have as much to do with chance and circumstances as with science. This experience is not heartening news for a profession struggling to develop a nosology based on science rather than culture.
What Is Catatonia?
As bacteriology successfully identified clinical conditions with specific infections, attempts were made to identify syndromes in other disciplines. Psychiatric practice in the 19th century was mainly an asylum-based experience, with an emphasis on the severely ill. In 1863, Kahlbaum described illnesses in mood and thought by their symptoms, physical signs, and course. 3 In succeeding years, as the director of a German sanitarium for people with long-term psychiatric illness at Görlitz, he focused his interest on motor disorders. His patients exhibited paralyses (as in neurosyphilis and cerebrovascular disease), repetitive movements (as dystonias, dyskinesias, and tremors), stupors, seizures, and excitement states. The rich mix of behaviours called for systemization and Kahlbaum identified catatonia in an 1874 treatise, Die Katatonie oder das Spannungsirresein. 2 Clinical vignettes of 26 patients documented his characterization:
[T]he patient remains entirely motionless, without speaking, and with a rigid, masklike facies, the eyes focused at a distance; he seems devoid of any will to move or react to any stimuli; there may be fully developed "waxen" flexibility, as in cataleptic states, or only indications, distinct, nevertheless, of this striking phenomenon. The general impression conveyed by such patients is one of profound mental anguish. 2, p 8 Among the probable causes of illness, 9 patients were suffering from a seizure disorder, 12 were depressed, 3 had neurosyphilis, and 2 had tuberculosis.
Kahlbaum had demarcated the syndrome so well that other psychopathologists quickly recognized similar cases and adopted his terminology. Within a few years, the incidence of catatonia was widely reported in 6% to 38% of people hospitalized with psychiatric illness.
Kahlbaum's delineation of the syndrome by physical signs and course of illness became a model for other delineations. His associate, Ewald Hecker, described a psychosis of early onset, silly affect, formal thought disorder, and progressive deterioration to dementia as hebephrenia. 4 The description anticipated the dementia praecox of Emil Kraepelin 5 and schizophrenia of Eugen Bleuler. 6 Kahlbaum and Hecker also described dysthymia, cyclothymia, and paranoia, names that resonate today in the psychiatric classification.
Catatonia as a Type of Schizophrenia
Catatonia was also recognized by Kraepelin 6 and MDI (in 1899). 7 These descriptions became the mainstays for psychiatric classifications for much of the 20th century.
Kraepelin described catatonia in both his patients with MDI and dementia praecox. Despite a better prognosis, catatonia became identified as a type of the progressive deteriorating illness of dementia praecox. Its appearance among the mood-disordered patients was not appreciated until decades later.
By 1900, Kraepelin's formulation was widely adopted in Germany and was brought to the United States by European emigrants. Among these was the Swiss neuropathologist Adolf Meyer. After numerous research positions in state hospitals, he became the head of psychiatry at Johns Hopkins Hospital in 1910. His treatment base shifted from the asylum to the hospital clinic. Following in the footsteps of Kraepelin and Bleuler, he turned more and more to the psychodynamic view of psychiatric illness. This shift is well demonstrated by his urge to change the label of manic-depressive insanity (Kraepelin) to depression. Meyer was:
[D]esirous of eliminating the term melancholia, which implied a knowledge of something that we did not possess, and which had been employed in different specific ways by different writers. If, instead of melancholia, we applied the term depression to the whole class, it would designate in an unassuming way exactly what was meant by the common use of the term melancholia; and nobody would doubt that for medical purposes the term would have to be amplified so as to denote the kind of depression . . . We might distinguish the pronounced types from the simple insufficiently differentiated depressions. Besides the manic-depressive depressions, the anxiety psychoses, the depressive deliria and depressive hallucinations, the depressive episodes of dementia praecox, the symptomatic depressions, non-differentiated depressions will occur. 8, p 198 Meyer pictured depressive mood disorders as individualized reactions:
The conditions which we meet in psychopathology are more or less abnormal reaction types, which we want to learn to distinguish from one another, trace to the situation or condition under which they arise, and study for their modifiability. 8, p 198 His image of psychiatric illness was strongly encouraged by the shift from asylum-to office-based psychiatry and the shift of psychiatric classifications away from medical disease concepts to psychodynamic-based formulations. These turned out to be fateful choices because, under the weight of Meyer's concepts, catatonia (and melancholia as well) lost its identity. 9
Where Is Catatonia in Psychiatric Classification?
Authors believed they discerned a decline in the incidence of catatonia. The change began in North America in 1917 with the publication of the Statistical Manual for the Use of Institutions for the Insane, a formulation developed by the American Medico-Psychological Association and the National Committee for Mental Hygiene, based on Kraepelinian formulation. The APA offered similar classifications in their DSMs of 1952, 1968, 1980, 1987, and 1994 . [10] [11] [12] [13] [14] Each formulation followed the Kraepelin classification, with catatonia as a type of schizophrenia.
The first classification officially sanctioned by the APA as DSM-I 10 adopted Meyer's descriptions of reactions rather than diseases. Catatonia was recognized as "schizophrenic reaction, catatonic type" 10, p 26 (000-x23). A 1968 reformulation to conform to the WHO ICD-8 15 classified catatonia as "schizophrenia, catatonic type" 15, p 33 (295.2). For American usage, the class allowed the subdivision into an excited type (295.23) and a withdrawn type (295.24). The reaction concept was deleted in the reformulation of DSM-III. 12 The revived interest in catatonia in the late 1970s and 1980s slightly affected the 1994 revision of DSM-IV. 14 In addition to catatonia as a schizophrenia type, "catatonia secondary to a general medical condition" 14, p 169 (293.89) was recognized, and catatonia was added as a features specifier of a mood episode.
A parallel international classification of medical disorders and causes of death is found in the ICD maintained by the WHO. Psychiatric syndromes were first included in the ICD-6 of 1949 16 and have been included in subsequent editions to the International Statistical Classification of Diseases and Related Health Problems (known as ICD-10) in 1992. 17 Catatonia is again recognized only as a type of schizophrenia (300.2) in each iteration. It is interesting that the nosological gaze reduced catatonia to such secondary status.
Where Have All the Catatonics Gone?
Although catatonia was an established and often recognized syndrome among severely ill psychiatric populations, it seemed to disappear in midcentury. In 1981, a writer asked "Where have all the catatonics gone?" suggesting that the change resulted from the increased use of psychotropic agents. 18 When I lectured on catatonia at academic centres in the 1990s, I often asked when members of the audience had last seen a case of catatonia. Often, indeed almost always, the senior members recalled their last experience while in training in state-supported facilities.
For the first half of the 20th century, psychiatric interest was focused on people with severe mental illness. The enthusiasm for Freudian concepts grew steadily after Freud's visit to the United States in 1909. By the Second World War, the enthusiasm dominated American psychiatry as culture took a hand over science.
The trend away from the care and interest in people with severe mental illness had already begun before the Second World War, as reflected in the psychiatric classification of 1952. However, after the war ended, psychoanalytic psychiatrists adopted an aggressive stance to dominate psychiatric practice. Broadsides of their policy arm, the Group for the Advancement of Psychiatry, attacked somatic psychiatry. As psychoanalysts dominated the principal American medical teaching centres, hundreds of physicians, and soon psychologists, social workers, and clergy, were encouraged to develop outpatient offices for psychotherapy.
The shift in interest from neuropathology and brain structures to mind and psychology led to a philosophical split in medical practice. What had been a single discipline became 2: neurology caring for patients with central nervous system disorders and psychiatry caring for the emotionally wounded. The specialty certifying American Board of Psychiatry and Neurology that once offered a single certificate split its training requirements into 2 examinations.
Psychiatric interest shifted from people with severe mental illness requiring protection and care in hospitals, to ambulatory people with complaints of anxiety, depression, obsessions, phobias, and problems in sexual identification. Catatonia, in its full-blown form of mutism and negativism, did not lend itself to verbal interaction but led to prompt referral for hospital care.
The physical examination was downgraded. Queries and responses during the interview were sufficient to make the diagnosis, with occasional support from psychological tests. Physical examination was abjured. Psychodynamic injunctions against touching or examining the patient hastened the flight from physical examination.
The same disregard for the physical examination is seen in psychopharmacology. Chlorpromazine and other antipsychotic agents are associated with motor rigidity, tremors, and dyskinesia. Early observers focused on these signs, just as they did on the changes in the electroencephalogram, as evidence that the drugs had central nervous system effects.
Efforts were made to measure antipsychotic activity by their impact on handwriting and reaction time tests. Even this limited interest was lost when checklist symptom rating scales were adopted as the measure of medication efficacy. Motor effects were degraded from measures of potency and efficacy to the indifference accorded side effects.
The successful deinstitutionalization of patients to halfway houses, the streets, prisons, and the few remaining statesupported psychiatric asylums further divided the venues in which catatonia was recognized and the ambulatory care facilities where it was not.
The changing styles in clinical examination and the shift of interest from people hospitalized with psychiatric illness to ambulatory patients strongly influenced the recognition of catatonia. The focus on psychotherapy and the prescription of psychoactive agents to ambulatory patients with psychiatric illness sustains the widespread belief that catatonia is no longer a feature of psychiatric care but a relic from earlier eras.
Catatonia Is Rediscovered in Academic Centres
By contrast with psychotherapy, where one treatment method fits all patients, psychoactive drugs have varied effects on psychiatric symptoms. The psychiatric classification based on reactions was unsatisfactory as predictors of treatment response. It offered no discriminating criteria and disregarded treatment outcome and laboratory tests as validators. Research groups found that they were using the same labels for populations that differed in behaviour, course of illness, and treatment response.
A random assignment study of all hospitalized patients referred for medication treatment to 6 weeks of either chlorpromazine, imipramine, or placebo was undertaken at Hillside Hospital in New York in the late 1950s. 19, 20 Patients with depression responded to imipramine and psychotic patients to chlorpromazine whether they were labelled as schizophrenia or MDI. Patients with phobias responded to imipramine. This study showed the inadequacy of the DSM-I diagnostic criteria for selection of the medications.
For a better diagnostic classification, the psychiatrists at Washington University examined the criteria using the medical model of diagnosis. 21 They scored predominant symptoms, followed the course of illness, sought laboratory tests for verification, and accepted treatment response as a diagnosis validator. In a critical 1975 study, 22 clinicians at the University of Iowa examined the records of patients (n = 2500) hospitalized with extended follow-up. Ten percent met criteria for catatonia. Examining the records of these patients (n = 250), 40% of those for whom follow-up information was available had, at some time, recovered completely. The symptoms classically associated with catatonia (catalepsy, posturing, staring, mutism, rigidity, grimacing, and negativism) were associated with a better prognosis than other types of schizophrenia. Morrison 22 concluded that catatonic symptoms warranted separate reporting in treatment and outcome studies.
A year later, Abrams and Taylor 23 reported their observations in patients (n = 55) with one or more catatonic signs. The patients had been admitted during 14 months to an acute inpatient psychiatric unit of a municipal hospital in New York City. Only 4 patients satisfied the research diagnostic criteria for schizophrenia, while more than two-thirds met the criteria for affective disorders, usually mania. They also described a favourable treatment response for the entire catatonic sample, with two-thirds markedly improved or in remission at the time of discharge, a finding that was inconsistent with the label of schizophrenia.
The same year, Gelenberg and Mandel 24 described patients (n = 8) receiving high-potency neuroleptic drugs who developed an acute syndrome of catatonia and parkinsonism. The syndrome yielded slowly to withdrawal of the neuroleptic or treatment with an anticholinergic agent.
In a review of more than 60 cases published in 1980 under the label of NMS, Caroff 25 argued that the syndrome was underrecognized and underdiagnosed. Using the criteria of hyperthermia, rigidity, altered consciousness, and autonomic instability proposed by Delay and Deniker, 26 Caroff 25 opined that the findings resulted from excess dopamine antagonism and urged dopamine agonists for treatment. In a confusing assertion, he also related the syndrome to that of malignant hyperthermia, a syndrome of muscle weakness and fever that follows the use of inhalational anesthetics in patients with an identifiable genetic fault. For the next few years, many authors treated NMS as Caroff suggested. The results varied, depending mainly on whether the physicians recognized the causal relation to antipsychotic drugs and immediately ceased their administration. Physicians who discontinued the offending agents saw relief of the syndrome; those who continued neuroleptic administration reported poor, often fatal, results.
Observers reporting cases of people with NMS were impressed by the signs of catatonia that marked the syndrome and the associated fever, autonomic signs, and confusion as similar to that reported in patients with MC. The similarity of NMS and MC led some to ask whether NMS was a variant of febrile MC. 27 The treatment of MC by benzodiazepines and ECT had been well established, and similar treatment trials in patients with NMS showed a similar efficacy. ECT was an effective treatment for NMS (as it was for MC). After much debate at annual meetings of the APA, NMS is now accepted as a form of MC with a defined toxic precipitant. Texts supporting this concept appeared in 2003 28 and 2004. 29 
Effective Treatments for Catatonia?
Bringing a syndrome such as catatonia back into view promotes a search for treatments. Kahlbaum's patients were ill for months, even years, recovering after an unusual emotional or traumatic experience, a febrile episode, or, most often, without reason. Kahlbaum offered hospital protection and tonics. He was opposed to bloodletting, laxatives, withdrawal of fluids in dieting, and taking the waters at spas, the popular treatments at the time. He found belladonna, zinc oxide, potassium bromide, and opium ineffective.
In 1930, William J Bleckwenn 30 reported that retarded catatonia was remarkably responsive to intravenous amobarbital. His silent films show the patients as mute, posturing, rigid, with heads raised fixedly from the pillow, and then responding dramatically to multigram doses of amobarbital. 31 The films were convincing, and amobarbital was quickly and widely used to obtain clinical histories and to allow feeding and self-care. (During my medical school training between 1942 and 1945, I routinely carried 2 vials of 500 mg amobarbital, a syringe, needles, sterile water, and a tourniquet on ward rounds. The incidence of catatonia, especially excited catatonia, was sufficiently common for such equipment to be in the hands of students and interns.)
In the 1980s, when the risks of the barbiturates led to their replacement by benzodiazepines, lorazepam and diazepam became effective replacements to relieve catatonia.
The demonstration that induced grand mal seizures relieved catatonia rapidly and effectively offered a second effective treatment in 1934. László Meduna, a Hungarian neuropsychiatrist, conceptualized an antagonism between epilepsy and psychosis and experimentally induced seizures first using injections of camphor 31 and later intravenous pentylenetetrazol (Metrazol). 32 Among the first 11 patients he treated to test his concept, 9 were catatonic. 33 His success with a catatonic man who had been ill for more than 4 years convinced him to expand his work. 34 His reports in 1935 and 1937 galvanized worldwide acceptance. As the treatment metamorphosed into ECT, its efficacy was repeatedly demonstrated so that ECT is now the definitive treatment for catatonia when barbiturates and benzodiazepines fail.
Reading the limited list of ineffective treatments available to Kahlbaum and to clinicians up to the 1930s, we can see how very far our options have come. This favourable result came from the efforts of a few clinicians who resisted the view that catatonia had disappeared.
How Many Faces Does Catatonia Show?
Catatonia is now recognized in retarded and excited forms. 28 The retarded form includes stupor when severe, with patients requiring parenteral feeding and extended nursing care while in life-threatening states. Posturing, rigidity, repetitive actions, mutism, and lack of response to stimulation mark the retarded form. Excitement, ceaseless agitation, and even delirium and furor mark the excited form. Retarded and excited states may occur in the same patient during a single day. These images are well described by Kahlbaum, Kraepelin, and the psychopathologists whose reports dot the literature of the first quarter of the 20th century.
A malignant form of acute onset, with rising fevers and vegetative imbalances of life-threatening dimensions, was described as MC by Stauder in 1934. 35 This form was also labelled pernicious or lethal catatonia. The patients are delirious, with rising fevers, abnormal blood pressures, tachycardia, and tachypnea. Mutism, rigidity, posturing, restlessness are marked. The definitive treatment with ECT was described in 1952 by Arnold and Stepan. 36 They described the need for intensive (daily) treatments within the first 5 days of the illness to prevent death.
The patients described as suffering a neurotoxic syndrome to neuroleptic drugs in the 1970s met the criteria for MC. In addition to rising fever, tachycardia and hypertension, they were delirious, mute, rigid, posturing, and negativistic. The NMS syndrome was considered a distinct entity until Rosebush and Stewart, 37 White and Robins, 38 and Fink and Taylor 39 argued that NMS was a form of MC, and best treated as such.
Catatonia was recognized in manic patients in the syndrome of "delirious mania" described by Bell. 40 The syndrome is occasionally cited as Bell's mania. In 1950, a small treatise by Meduna titled Oneirophrenia focused interest on delirium as its most prominent feature. 41 Bond 42 later described delirious patients who responded to lithium therapy. More recent case reports find the syndrome rapidly responsive to daily ECT. 43 Catatonia in adolescents and children responds rapidly to ECT. Catatonia is prominent among patients with mental retardation and is a treatable aspect of this disorder. 44 It is found in adolescents and children with autism spectrum disorders-syndromes characterized by poor sociability, speech and motor impediments, and repetitive behaviours that are often self-injurious. Examples are brought together in Catatonia in Autism Spectrum Disorders. 45 The repetitive nature of self-injurious behaviour and the response to treatment for catatonia is described in case reports. [46] [47] [48] [49] Vocal and motor tics, echolalia, and echopraxia characterize the repetitive behaviour in Gilles de la Tourette syndrome. It is usually discerned in children but a few cases have also been described in adults. 50 The syndrome is optimistically viewed as a catatonia variant.
Where Does Catatonia Belong in Psychiatric Classification?
What conclusions can be drawn from this wealth of descriptive psychopathology that highlights catatonia as a diagnosable and treatable syndrome? Psychosis, melancholia, delirium, dementia, and epilepsy are syndromes with multiple etiologies that are identified as syndromes in classical psychopathology. Defined signs characterize each. In some instances, the syndrome is verified by laboratory tests and validated by defined treatments.
Catatonia is such a syndrome. It is well described by its characteristic motor psychopathology, verified by acute response to amobarbital or lorazepam, and validated by the treatment with high doses of benzodiazepines or ECT. It is no longer tenable to limit its ascertainment as a type of schizophrenia (which it is rarely), as a features specifier for affective illness, or as secondary to a general medical condition, as proffered by the present DSM-IV classification. Catatonia is a well-defined syndrome that is sui generis, deserving of a home of its own in the psychiatric nomenclature as a specific psychopathology with many different faces. It deserves to be freed from schizophrenia and recognized in its own right . 28, 51 Separating catatonia from its bond to schizophrenia has the benefit of a proper diagnosis that promises effective treatment. It discourages the reflex prescription of neuroleptic drugs, hazarding the risks of ineffective treatment and a neurotoxic syndrome.
Defining Melancholia as a Syndrome in the Medical Model
Other illnesses have similarly disappeared from medical vision-and reappeared with exclamations of discovery -without really changing in frequency. The successful delineation of catatonia as an identifiable and treatable syndrome in psychopathology encouraged a similar examination of major depression and bipolar disorder. Melancholia is a form of depressive illness that has been described in the medical literature for centuries. Prominent 19th-century psychopathologists as Falret 52 and Baillarger 53 described a circular insanity, and Kraepelin made MDI a prominent part of his classification. Nonetheless, depression and mania were distinguished as unique entities in the 1980 DSM-III classification, supported by the writings of Rush and Weinberger 54 and Goodwin and Jamison. 55 By contrast, Taylor and Fink 56 and Parker and Hadzi-Pavlovic 57 applied the medical model to delineate the syndrome of melancholia as the classical single encompassing syndrome.
Melancholia is defined as a severe alteration in mood with abnormal motor functions and disturbed vegetative signs. Depression and motor symptom rating scales offer guides to the diagnosis by recognizing the principal characteristics of the syndrome. The physical examination records the vegetative signs.
Abnormal cortisol physiology is a marker of melancholia.
(To be sure, it is not specific to melancholia, yet it alerts us to a group of people with melancholia with an underlying biological homogeneity.) An abnormal dexamethasone suppression test (or its modifications) verifies the diagnosis. The successful treatment with either tricyclic antidepressants or ECT validates the diagnosis.
Similar to catatonia with its many different forms, melancholia presents many faces. 56 Major unipolar depression, psychotic depression, bipolar depression, manic depression, puerperal depression, and abnormal bereavement are syndromes in the classifications that often meet the criteria for melancholia. There is little reason to persist in dividing the mood disorders as unipolar and bipolar depression, or as major depression and bipolar disorder, because the definition of these syndromes is unstable, does not allow for verification by laboratory tests, does not specify the significance of motor and vegetative symptoms, and is not validated by effective treatment response. The present classification does not assure useful treatment algorithms; many studies based on these criteria assessing modern antidepressants find them little better than placebos. 58
Lessons From the Study of Catatonia
In his In Review paper, Dowbiggin 59 comments on syndromes with apparent stability over time that do in fact change in frequency. Here we consider the syndrome of catatonia with apparent changeability that possesses an underlying biological stability: we have learned that catatonia is a defined syndrome in psychopathology that has useful tests for verification and effective treatments. It comes in many forms, most commonly described as retarded, excited, and malignant (encompassing NMS). It is associated with mania and depression, seizures, and infections, and as a toxic response to drugs. It occurs in patients of all ages. Most remarkably, the motor aspects are quickly responsive to sedation with barbiturates and benzodiazepines. (This benefit often requires larger than customary doses of the agents.) The syndrome is also unique in the immediacy of its response to ECT.
Identification of catatonia as a syndrome offers more reliable diagnoses and effective treatments. NMS is a form of catatonia that is now well documented. Children and adolescents with autism spectrum disorders and mental retardation who exhibit posturing, withdrawal, and self-injurious and other repetitive behaviours may be exhibiting a treatmentresponsive form of catatonia. Gilles de la Tourette and obsessive-compulsive disorder warrant reassessment as variants of catatonia. Similarly, patients with postencephalitic parkinsonism as mute, posturing, rigid, and with repetitive behaviours, and their treatment with dopamine agonists, warrant reassessment as catatonia.
It is inexcusable that the psychiatric classification persists in recognizing catatonia only as a type of schizophrenia. Not only is catatonia uncommon among patients with schizophrenia, but the popular treatment for schizophrenia-the administration of neuroleptics-is ineffective, and indeed dangerous, as it may augment or precipitate a malignant form of catatonia. Catatonia deserves a home of its own in the psychiatric classification, akin to delirium and dementia.
The application of the medical model to melancholia defined another syndrome that is remarkably responsive to treatment. Application of the model to the psychiatric disorders of atypical depression, attention-deficit hyperactivity disorder, panic disorder, and postpartum psychosis, where potential tests and effective treatments are known, may be as productive.
Psychiatric classification is roiled by a plethora of opinions, based on clinical impressions without recourse to external or independent verification. The dimension model, which retains pride of place, is based on the belief that emotional disorders are variants of normal behaviours, with reactions to stress as the basic model. This model does not apply to catatonia. Catatonia is a syndrome sui generis and its separate delineation is as useful as the delineation of any bacterial infection.
Melancholia is another syndrome that does not lend itself to a dimensional model. Nor is the model appropriate for delirium, dementia, and epilepsy. It would be more productive to define the behaviour syndromes of interest to psychiatry using the medical model than suffer another reiteration of the nonproductive dimensional model as applied in the iterations of the DSM and ICD classifications.
The story of catatonia-its recognition, disappearance, and resurrection in clinical psychiatry-reflects the profound changes that have occurred in clinical practice. The change to an office-based practice denigrated clinical psychopathology from a discipline of scientific promise to a faith-based program on the weak and often ineffective interventions of social and verbal treatments with markers based almost wholly on checklist rating scales without place for physical or laboratory examination. In the present reexamination of the psychiatric classification, a return to classical psychopathology and a search for syndromes that are best defined by the medical model would be salutary.
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Résumé : La catatonie : un syndrome apparaît, disparaît, et est redécouvert
La catatonie est un syndrome psychiatrique de fonctions motrices perturbées parmi des perturbations de l'humeur et de la pensée, qui a d'abord été décrit en 1874. Elle a rapidement été observée chez 10 % à 38 % des populations psychiatriques. Après qu'elle a été liée à la schizophrénie comme type dans la classification psychiatrique, sa reconnaissance est devenue de plus en plus limitée, si bien que dans les années 1980, on se demandait où étaient passés les catatoniques. Le déclin est largement attribuable au changement d'endroit de la pratique psychiatrique, de l'asile au bureau, au rejet de l'examen physique, et à la dépendance aux échelles d'évaluation pour le diagnostic.
Dans les années 1970, de grandes enquêtes ont montré de nouveau que la catatonie était aussi répandue qu'auparavant chez les patients souffrant de manie et de dépression, et comme réaction toxique aux neuroleptiques. Cette dernière constatation, que le syndrome malin des neuroleptiques est le même syndrome que celui de la catatonie maligne, et qu'il est efficacement traité comme tel, a suscité un nouvel intérêt. Les cliniciens ont élaboré des échelles d'évaluation pour identifier le syndrome de la catatonie et appliqué le soulagement immédiat procuré par un barbiturique ou une benzodiazépine comme test diagnostique, le test au lorazépam. Les traitements efficaces ont été décrits à hautes doses de benzodiazépines et d'électrochocs.
Les enquêtes utilisant les échelles d'évaluation de la catatonie ont montré que celle-ci avait plusieurs visages. La catatonie est présentement limitée à un type de schizophrénie dans la classification psychiatrique. Elle devrait désormais être reconnue comme étant un trouble en elle-même, comme le délire ou la démence. Cette expérience a renforcé l'utilité du modèle médical pour le diagnostic. Une application pour la mélancolie est décrite.
